Vinelbine Injection 5 ml belongs to the group of medicines called vinca alkaloids used alone or in combination with other anti-cancer medicines to treat non-small cell lung cancer that has spread to other body parts and advanced breast cancer that has not responded to other medicines.

Vinelbine Injection 5 ml contains Vinorelbine, which works by stopping or slowing the growth of cancer cells in the body.

In some cases, Vinelbine Injection 5 ml may cause side effects such as nausea, vomiting, constipation, injection site reactions, and a decrease in white and red blood cells. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.

Do not use Vinelbine Injection 5 ml if you are pregnant, breastfeeding, or think you may be pregnant. Vinelbine Injection 5 ml is not recommended for children below 18 years. Inform your doctor about your health condition and medications to rule out any side effects/interactions.

Vinelbine Injection 5 ml is used in the treatment of Non-small cell lung cancer and breast cancer. The detailed uses of Vinelbine Injection 5 ml are as follows:

• Non-Small Cell Lung Cancer (NSCLC) : Vinelbine Injection 5 ml is often used as a first-line or palliative treatment for non-small cell lung cancer, either alone or in combination with other agents.
• Metastatic Breast Cancer: Vinelbine Injection 5 ml is used to treat metastatic breast cancer especially in patients who have not responded to first-line chemotherapy.

• Follow your doctor’s instructions on the dosage and timing of this medication.
• Vinelbine Injection 5 ml will be administered in a hospital setting under the supervision of a physician qualified by training and experience to administer cancer chemotherapeutic agents.
• Do not self-administer.

Vinelbine Injection 5 ml belongs to the group of medicines called vinca alkaloids used to treat locally advanced or metastatic non-small cell lung cancer and advanced breast cancer that has not responded to other medicines. It may also be used to treat cancer of the oesophagus and soft tissue sarcoma (cancer that forms in the muscles). Vinelbine Injection 5 ml contains Vinorelbine, which works by stopping the growth and multiplication of cancer cells. 

Do not use Vinelbine Injection 5 ml if you are allergic to any of its components, if you are pregnant, think you might be pregnant or breastfeeding, if you have low white blood cell count, have/had a severe infection within two weeks, have thrombocytopenia (low platelet count), or if you have taken or plan to receive yellow fever vaccination. Inform the doctor if you have a history of heart attack, severe chest pain, liver problems, and signs or symptoms of infection. Consult the doctor immediately if you become pregnant during treatment with Vinelbine Injection 5 ml. Seek immediate medical attention if you experience symptoms of pulmonary embolism (chest pain, breathlessness, and fainting), posterior reversible encephalopathy syndrome (headaches, changed mental state which may lead to confusion and coma, convulsions, blurred vision and high blood pressure), infection (cough, fever, and chills), severe constipation with abdominal pain, acute respiratory distress syndrome (difficulty breathing), severe reduced blood pressure (severe dizziness and lightheadedness when you stand up), severe chest pain, or allergic reactions (dizziness, rash, swelling of the eyelids, face, lips or throat).